Healio
Three months after the ADJUST-T1D trial ended, people who had been on semaglutide saw time in range drop 3.6 points, while those on placebo gained 1.5 points.
Recap by typeshit. Full story at Healio.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
Healio
Biykem Bozkurt told the Cardiometabolic Health Congress that semaglutide and tirzepatide improve weight, exercise capacity and quality of life in obese HFpEF patients.
Christian Djurhuus and Nicholas Alp join moderator Bob DiLuzio in an Xtalks session on keeping people engaged with obesity care over time.
Loading…